Novoheart announced today that its MyHeartTM platform, including the world’s first and only ‘human heart-in-a-jar’, has been selected as 2018’s “Best New Technology Solution – Drug Development” by MedTech Breakthrough, an independent organization that recognizes the top companies, technologies and products in the global health and medical technology market.
The mission of the annual MedTech Breakthrough Awards is to honor excellence and recognize innovation, diligence, and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,000 nominations from over 12 different countries across the globe. Previous award winners include HP, Nike, IBM Watson, Apple and WebMD.
For details of the MedTech Breakthrough Awards 2018, please click here.
For more detailed press release, please click here.